Kainos Group plc is a UK–headquartered provider of Digital Services and Digital Platforms.
Re–Vana Therapeutics is an ocular pharmaceuticals and drug delivery company focused on the development and commercialisation of innovative long–acting biodegradable drug delivery platforms to treat chronic eye diseases.
Fusion Antibodies is dedicated to the discovery and early development of antibodies to help bring about a positive change in the healthcare industry.
Tailored software and consultancy packages for timetabling, scheduling, resource and space planning within the education, training and public sectors.